Loading...
XASESSY
Market cap5mUSD
Dec 24, Last price  
0.77USD
1D
-0.01%
1Q
-8.35%
Jan 2017
-36.16%
Name

SunLink Health Systems Inc

Chart & Performance

D1W1MN
XASE:SSY chart
P/E
—
P/S
0.17
EPS
—
Div Yield, %
0.00%
Shrs. gr., 5y
-0.31%
Rev. gr., 5y
-6.59%
Revenues
32m
-32.34%
128,732,000135,576,000143,645,000158,431,000199,254,000197,784,000181,161,000146,674,000108,225,000105,430,00091,833,00063,433,00053,288,00052,872,00045,618,00047,813,00040,685,00041,344,00047,949,00032,440,000
Net income
-2m
L-14.93%
4,540,0003,909,0001,396,0001,616,000912,000102,000-10,715,0001,081,0004,488,000-545,000245,000-14,083,0002,688,000-1,593,000-1,996,000-586,0006,890,000-1,722,000-1,795,000-1,527,000
CFO
-3m
L+451.48%
2,225,0004,506,0004,749,0001,680,0004,430,0003,928,0004,779,0003,082,000-2,016,0003,892,0002,938,000-426,000-5,610,000396,000-1,427,0003,969,0001,365,000-4,000-540,000-2,978,000
Dividend
Nov 22, 19930.262 USD/sh
Earnings
Feb 11, 2025

Profile

SunLink Health Systems, Inc., through its subsidiaries, provides healthcare products and services in the southeastern United States. It operates through two segments, Healthcare Services and Pharmacy. The Healthcare Services segment owns and operates an 84-bed community hospital, which includes an 18-bed geriatric psychiatry unit; and a 66-bed extended care and rehabilitation center. This segment also provides information technology services; and owns unimproved lands. The Pharmacy segment offers institutional and non-institutional pharmacy services; and durable medical equipment products and services, including the sale and rental of products for institutional clients or to patients in institutional settings and patient-administered home care, as well as retails pharmacy products and services. SunLink Health Systems, Inc. was incorporated in 1959 and is based in Atlanta, Georgia.
URL
http://www.sunlinkhealth.com/
IPO date
Mar 18, 1980
Employees
1,376
Domiciled in
US
Incorporated in
US

Valuation

Title
USD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2024‑062023‑062022‑062021‑062020‑062019‑062018‑062017‑062016‑062015‑06
Income
Revenues
32,440
-32.34%
47,949
15.98%
41,344
1.62%
Cost of revenue
30,464
43,743
40,796
Unusual Expense (Income)
NOPBT
1,976
4,206
548
NOPBT Margin
6.09%
8.77%
1.33%
Operating Taxes
(5)
(7)
107
Tax Rate
19.53%
NOPAT
1,981
4,213
441
Net income
(1,527)
-14.93%
(1,795)
4.24%
(1,722)
-124.99%
Dividends
Dividend yield
Proceeds from repurchase of equity
6
48
BB yield
-0.11%
-0.75%
Debt
Debt current
331
409
392
Long-term debt
725
1,757
2,080
Deferred revenue
Other long-term liabilities
229
240
192
Net debt
(6,114)
(2,389)
(4,322)
Cash flow
Cash from operating activities
(2,978)
(540)
(4)
CAPEX
(1,467)
(2,000)
(3,190)
Cash from investing activities
5,670
(1,776)
(3,128)
Cash from financing activities
(8)
8
(36)
FCF
8,651
1,732
1,846
Balance
Cash
7,170
4,486
6,794
Long term investments
69
Excess cash
5,548
2,158
4,727
Stockholders' equity
5,226
6,671
8,384
Invested Capital
11,504
16,582
13,248
ROIC
14.11%
28.25%
3.08%
ROCE
11.81%
22.36%
3.04%
EV
Common stock shares outstanding
7,038
7,019
6,945
Price
0.80
-12.09%
0.91
-9.02%
1.00
-70.75%
Market cap
5,630
-11.85%
6,387
-8.05%
6,946
-70.94%
EV
(484)
3,998
2,624
EBITDA
3,578
5,971
2,091
EV/EBITDA
0.67
1.26
Interest
15
Interest/NOPBT
2.74%